Latest News

6 07, 2021

QV Bioelectronics Raises £735k for development of implanted electric field therapy device for brain cancer treatment.

2021-07-06T11:12:21+01:00July 6th, 2021|

• £735k seed financing raised from VC and angel investors. • The capital will be used to advance development of the GRACE implant, to treat brain tumour patients with electric field therapy, whilst also expanding the team and accelerating the collection of preclinical data • The preclinical safety and efficacy data will provide preclinical proof [...]

17 12, 2020

QV Bioelectronics Announced as Competition Winner in the North

2020-12-17T12:17:55+01:00December 17th, 2020|

We were proud to have been announced as the Super Connect for Good 2020 Northern Regional Winners. Thanks again to Empact Ventures and Hays for putting together a great event. Fantastic to have been alongside a huge range of terrific startups. Huge thank you again to the judges for awarding us Northern regional winners, and to the kind quotes [...]

6 11, 2020

Joel Treen joins as new head of Quality and Regulatory Affairs Manager

2020-12-17T12:18:41+01:00November 6th, 2020|

We are delighted to announce that Joel Treen has joined us as our Quality and Regulatory Affairs Manager. Joel is an engineer with substantial experience in the design, development and bringing to market of medical devices. He has developed a variety of class I to III devices, within the orthopaedic sector especially, from simple single-use [...]

4 08, 2020

Dr Paul Brennan joins QV Bioelectronics as Clinical Advisor

2020-12-17T12:19:03+01:00August 4th, 2020|

QV Bioelectronics is delighted to announce that Dr Paul Brennan will be joining our clinical advisory board & our design input group! Paul is Reader and Honorary Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian. He combines his operative expertise with laboratory and clinical research into brain tumours. He has expertise in MedTech [...]

24 06, 2020

QV Bioelectronics Receive £115,000 in Innovate UK Funding

2020-12-17T12:18:51+01:00June 24th, 2020|

QV Bioelectronics has received funding from the UK's innovation agency, Innovate UK to continue developing our life-extending treatment option for terminal cancer patients. The Manchester based start-up has received co-funding from the UK's innovation agency, Innovate UK to support further device development. Funding from Innovate UK's SMART scheme will assist QV Bioelectronics in further prototyping, [...]

20 04, 2020

QV Bioelectronics Receive £150,000 in NIHR Funding

2020-12-17T12:19:11+01:00April 20th, 2020|

QV Bioelectronics is pleased to announce that is has been awarded £150,000 in funding from the NIHR (National Institute for Heath Research) Invention for Innovation (i4i) programme. The i4i award will fund additional prototype engineering over the next 12 months.  This will help us continue the development of our device which aims to improve the [...]

12 02, 2020

Dr Nimrah Munir Joins as Principal Biomaterials Scientist

2020-12-17T12:19:27+01:00February 12th, 2020|

We are delighted to announce that Dr Nimrah Munir has joined QV as our Principal Biomaterials Scientist. Dr Munir is a bioengineer with expertise in biomaterial production and characterisation. Following on from her undergraduate degree in Applied Pharmacology, where she received The Royal Society of Biology top student award (2015) at Queen Margaret University, Nimrah [...]

7 01, 2020

Hani Marcus Joins as Clinical Advisor

2020-01-07T15:59:33+01:00January 7th, 2020|

QV Bioelectronics are proud to announce the addition of Mr Hani Marcus as a member of our clinical advisory board and our design input group. Hani beings with him a wealth of expertise and experience, he currently acts as an academic consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery. He was among the [...]

8 10, 2019

QV Win BioCap 2019 Call for Pitches Competition

2019-10-29T17:09:54+01:00October 8th, 2019|

Co-Founder Chris won the annual BioCap Call for Pitches 2019 competition.  Chris gave an engaging 5-min pitch of the business and how our technological developments at QV aim to help glioblastoma patients. Coming out ahead against 7 other finalists,  Chris impressed not only the audience but a panel of experienced judges. "Chris gave a clear [...]

16 09, 2019

QV Join RebelBio Accelerator

2019-10-29T14:36:39+01:00September 16th, 2019|

QV is proud to announce that we are joining the world-class RebelBio Accelerator program at Imperial College's White City Campus in London. RebelBio (run by VC-firm SOSV), only accept 1.3% of start-up applicants onto their program, with successful graduates of the program including Perfect Day, Chronomics and Algiknit. As part of the 3-month program, we've [...]